![]() “HCAP delivers the power of machine learning and patient analytics to inform market understanding and support intelligent decision-making,” said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. ![]() ![]() I look forward to further advancements from our Analytics team.” I’d like to congratulate the HCAP team, led by Eddie Li, Travis Ruch, Birnur Ozbas-Erdem and Jing Li, for their dedicated work on this project. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements. “For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA when they need clarity and solutions to the industry’s most complex issues. “The development and launch of HCAP is an exciting achievement for CRA and reflects our commitment to generating value through innovation,” said CRA’s President and Chief Executive Officer Paul Maleh. Developed by CRA’s Life Sciences Practice, HCAP is a modular, dynamic, data-visualization tool that provides streamlined analysis of patient, Health Care Practitioner (HCP), and Health Care Organization (HCO) data to support insight generation and decision-making. ![]() BOSTON-( BUSINESS WIRE)- Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the launch of the Company’s new data analytics suite, the Healthcare Claims Analytics Platform (HCAP), at the World Orphan Drug Congress USA 2022 in Boston. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |